SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-006923
Filing Date
2021-01-12
Accepted
2021-01-12 10:59:02
Documents
13
Period of Report
2021-01-12
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d102109d8k.htm   iXBRL 8-K 64258
  Complete submission text file 0001193125-21-006923.txt   232764

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pfe-20210112.xsd EX-101.SCH 4524
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20210112_def.xml EX-101.DEF 13708
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20210112_lab.xml EX-101.LAB 22717
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20210112_pre.xml EX-101.PRE 14676
6 EXTRACTED XBRL INSTANCE DOCUMENT d102109d8k_htm.xml XML 6259
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 21522735
SIC: 2834 Pharmaceutical Preparations